Table 1.

Relation of ADAMTS13 activity to clinical categories of 142 patients with clinically diagnosed TTP-HUS



ADAMTS13 activity categories, no. of patients (%)
Clinical categories, (no. of patients)
Less than 5%
5%-9%
10%-25%
More than 25%
Stem cell transplantation (7)   0   0   1 (14)   6 (86)  
Pregnant/postpartum (10)   2 (20)   0   0   8 (80)  
Drug associated (21)   0   0   1 (5)   20 (95)  
Bloody diarrhea (10)   0   1 (10)   0   9 (90)  
Additional/alternative disorders (46)   0   2 (4)   10 (22)   34 (74)  
Idiopathic (48)   16 (33)   4 (8)   11 (23)   17 (36)  
Total patients (142)
 
18 (13)
 
7 (5)
 
23 (16)
 
94 (66)
 


ADAMTS13 activity categories, no. of patients (%)
Clinical categories, (no. of patients)
Less than 5%
5%-9%
10%-25%
More than 25%
Stem cell transplantation (7)   0   0   1 (14)   6 (86)  
Pregnant/postpartum (10)   2 (20)   0   0   8 (80)  
Drug associated (21)   0   0   1 (5)   20 (95)  
Bloody diarrhea (10)   0   1 (10)   0   9 (90)  
Additional/alternative disorders (46)   0   2 (4)   10 (22)   34 (74)  
Idiopathic (48)   16 (33)   4 (8)   11 (23)   17 (36)  
Total patients (142)
 
18 (13)
 
7 (5)
 
23 (16)
 
94 (66)
 

ADAMTS13 activity was measured on serum samples collected immediately before the first plasma exchange treatment on 142 (88%) of 161 consecutive patients with clinically diagnosed TTP-HUS. Clinical categories are defined in “Patients and methods.”

Close Modal

or Create an Account

Close Modal
Close Modal